Germline mutations in the tumor suppressor, BRCA2 (BReast CAncer susceptibility gene 2), have commonly been associated with an increased risk of developing breast and ovarian cancers (Connor et al., 1997; Kinzler & Vogelstein, 1997; Yoshida & Miki, 2004). Here, BRCA2 is linked to ovarian carcinoma.